Back

Incorporating right ventricular function into the Eeuropean modified Mayo staging system for improved prognosis in light chain amyloidosis

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Predicting outcomes in cardiac amyloidosis Infiltrative Myocardial Disease ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Gabriela Neculae

Institute of Cardiovascular Diseases Prof. C.C. Iliescu, Bucharest (Romania)

6 More presentations in this session

Presentation thumbnail
Aortic calcium scoring from computed tomography for signal localization by bone scintigraphy to predict aortic stenosis and assess prognosis in patients with transthyretin cardiac amyloidosis
Mr B. Guillaume (Toulouse, FR)
Abstract Slides Video
Presentation thumbnail
Prognostic value of heart failure hospitalization in transthyretin cardiac amyloidosis: an international cohort study
Doctor D. Laenens (Mechelen, BE)
Abstract Slides Video
Presentation thumbnail
Sex-based differences in phenotypic expression and prognosis of transthyretin cardiac amyloidosis associated with the Val122Ile variant
Doctor A. Monfort (Fort-de-France, MQ)
Abstract Slides Video
Presentation thumbnail
The incidence of death and risk factors for mortality in cardiac amyloidosis: an observational study in the UK clinical setting using electronic health records
Doctor L. Anderson (London, GB)
Abstract Slides Video
Presentation thumbnail
Myocardial stiffness and mortality risk in cardiac amyloidosis: a shear wave elastography analysis
Doctor C. Espinoza Romero (Sao Paulo, BR)
Abstract Slides Video

Access the full session

Session thumbnail
Predicting outcomes in cardiac amyloidosis

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Distribution and prognostic impact of left and right systolic and diastolic functions in wild-type transthyretin amyloid cardiomyopathy
thumbnail
Congress Presentation
Echocardiographic risk stratification in light chain and transthyretin amyloidosis: a meta-analysis
thumbnail
Congress Presentation
Baseline serum sodium as a non-negligible factor predicting increased risk of 3-month mortality in patients with light-chain amyloidosis diagnosed in cardiology department

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources